“arteaus-therapeutics” Archives

in
Entry Author Date Location
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
After Biogen Deal Fizzles, Rodin Bags $27M And Heads To First Trial 09/18/17 Boston
In Race to Relief, Amgen Touts New But Incomplete Migraine Data 06/09/16 San Francisco
Ever Fond of Options, Atlas Finds Potential Buyers For Rodin, Quartet 01/06/16 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout 02/04/15 Boston
Labrys Turns Stalled Pfizer Program into $200M+ Teva Buyout 06/03/14 San Francisco
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Alder Biopharma Looks to Take On Migraines, and the World 01/24/13 Seattle
Third Rock Launches Sage, Glaxo Malaria Vaccine Relies on Agenus Technology, Vertex Seeks Approval of Cystic Fibrosis Drug, & More Boston-Area Life Sciences News 10/21/11 Boston
Arteaus, With $18M From Atlas and OrbiMed, Forges Ahead on Migraine-Prevention Drug 10/19/11 Boston
Arteaus Therapeutics Lands $18,000,000 New Funding 10/19/11 Boston
Page 1 of 1